Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.


SkinVision is a CE-marked app that aims to drive early detection of skin cancer by enabling patients to take photos of their skin spots and receive a risk indication with recommendations for next steps.

  • Managing the backlog
  • Virtual care
  • Self-management
SkinVision logo

When diagnosed early, skin cancer is easier and less expensive to treat, and its prognosis is more favorable. However, most patients don’t know what to look for, resulting in unnecessary consultations and further pressure on a system under strain from a shortage of dermatologists. This leads to both over and under treatment, with unnecessary costs being tied up in the skin cancer pathway.

SkinVision puts the skin cancer assessment into the hands of patients, before they make a GP appointment, and directs them to the appropriate next step based on the app’s AI recommendation and/or the SkinVision dermatology team.

With nearly 200,000 users in the UK (1.3m users globally), SkinVision is used to perform 1,500 skin checks every day. The app’s algorithm processes user photos through deep neural networks and classifies them based on similar frameworks identified from other skin cancer photos in the database. Users can understand the level of risk for a skin spot instantly.

SkinVision can be used to address the two week wait list, post referral, as well as a part of the follow-up pathway for remote monitoring.